InvestorsHub on MSN

VivoSim reports first commercial sales in China for NAMkind testing services (NASDAQ:VIVS)

Key Investor Takeaways ・VivoSim (NASDAQ:VIVS) secured its first commercial sales in mainland China through two paid customer ...